Lotus Pharm vs Lumosa Therapeutics: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Lumosa Therapeutics (6535) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Lumosa Therapeutics

0%+9778%-99%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYLumosa TherapeuticsYoY
Oct 2026NT$2.13 billion-22.5%NT$78,000-54.9%
Sep 2026NT$2.77 billion+128.0%NT$211,000-95.1%
Aug 2026NT$2.11 billion+81.7%NT$9.1 million+5,135.8%
Jul 2026NT$2.49 billion+3.9%NT$78,000-98.9%
Jun 2026NT$3.4 billion+225.5%NT$5 million+233.5%
May 2026NT$2.32 billion+105.8%NT$78,000-64.5%
Apr 2026NT$3.09 billion+19.9%NT$78,000-83.4%
Mar 2026NT$4.35 billion+173.6%NT$503,000-94.3%
Feb 2026NT$2.24 billion+131.5%NT$30,000-25.0%
Jan 2026NT$2.05 billion-5.5%NT$4 million+9,777.5%
Dec 2025NT$2.44 billion+66.9%NT$14 million-19.3%
Nov 2025NT$1.06 billion-0.2%NT$173,000-95.8%
Oct 2025NT$2.75 billion+46.0%NT$173,000+332.5%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16